SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2506)6/8/2009 4:21:06 PM
From: Jibacoa  Respond to of 3722
 
ATRC is up 29.75% on volume of > 344,200 which is almost 3x its ADV

The stock had not fully closed its previous UG of May 5 and is trading above its May 7 H of $3.49

bigcharts.marketwatch.com

ATRC was able to trim its loss on the 1stQ to $0.08 from $0.25 in 2008 The EL for 2009 is around $0.30 vs. $0.71 in 2008 and for 2010 a further trim to $0.01 is expected.<g>

The insiders have been consistent buyers since Nov. and reportedly hold >20%

On March 27 it announced FDA clearance for its cryoablation system.

finance.yahoo.com

With some good 'news', it seems that the stock could get to close some of its Nov DG above the $4 level.

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (2506)8/3/2009 12:42:05 PM
From: Jibacoa  Read Replies (2) | Respond to of 3722
 
KERX is up 46.09% with volume > 6x its ADV.<g>

The stock opened with another UG

bigcharts.marketwatch.com

It announced today that it has reached agreement with the FDA regarding a Special Protocol Assessment on the design of a PIII for its KRX-0401 in MM patients previously treated with VELCADE.

With some good news the stock could get to close some of its March 2008 DG.<g>

bigcharts.marketwatch.com

Bernard